logo inner

Associate Director, Clinical Quality Assurance

4D Molecular TherapeuticsEmeryville, California, United StatesOnsite

Attention recruitment agencies:


All agency inquiries are vetted through 4DMT’s internal Talent Acquisition team. No unsolicited resumes will be accepted. The 4DMT Talent Acquisition team must expressly engage agencies on any requisition. Agencies contacting hiring managers directly will not be tolerated, and doing so may impact your ability to work with 4DMT in the future.4DMT is a clinical-stage biotherapeutics company harnessing the power of directed evolution for targeted genetic medicines. We seek to unlock the full potential of gene therapy using our platform, Therapeutic Vector Evolution (TVE), which combines the power of directed evolution with our approximately one billion synthetic AAV capsid-derived sequences to invent evolved vectors for use in our products.

We believe key features of our targeted and evolved vectors will help us create targeted product candidates with improved therapeutic profiles. These profiles will allow us to treat a broad range of large market diseases, unlike most current genetic medicines that generally focus on rare or small market diseases.  Company Differentiators: •    Fully integrated clinical-phase company with internal manufacturing•    Demonstrated ability to move rapidly from idea to IND•    Five candidate products in the clinic and two declared pre-clinical programs•    Robust technology and IP foundation, including our TVE and manufacturing platforms•    Initial product safety and efficacy data substantiates the value of our platforms•    Opportunities to expand to other indications and modalities within genetic medicine

Position Summary: 


The Associate Director of Clinical Quality Assurance (CQA) will be responsible for supporting Quality Assurance oversight of 4DMT sponsored clinical studies, ensuring studies are executed in compliance with all applicable international regulatory requirements for Good Clinical Practice (GCP).  This position reports to the Senior Director, GCP Compliance and Quality Systems and contributes to the development, implementation, and successful execution of the CQA mission, objectives, and strategic plan.

Responsibilities:


Provide Quality oversight for multiple 4DMT Clinical Studies, including the following study-specific activities:


  • Partner with Clinical stakeholder to support timely identification, escalation, investigation, documentation, and resolution of GCP-related quality events, acting at all times with an appropriate sense of urgency.
  • Provide GCP guidance to clinical study teams, including via attendance at Study team meetings, with support from Sr. Director GCP Compliance.
  • Ensure principles of Risk Management are applied to Clinical Studies per ICH E6
  • Coordinate GCP Compliance audits of high-risk clinical vendors/sites, including clinical investigator sites.
  • Ensure audit findings are communicated to audit stakeholders and collaborate with auditees and vendors to track, review, approve, and assess the adequacy of
  • Perform Clinical Document reviews, ensuring the quality, accuracy and completeness of various documents, including as applicable Clinical Protocols, IBs, DSURs, Module 2.6 Tabulated and Written Summaries, and Integrated

Support investigation and management of specific Clinical Study Quality Events as assigned:


  • Monitor, track, and facilitate the completion of formal corrective and preventive actions (CAPAs) to address identified Clinical Study Quality Events, including potential serious breaches of GCP. 

Support a quality-focused work environment in Clinical that fosters learning, respect, open communication, collaboration, integration, and teamwork:


  • Drive the development and continuous improvement of the Clinical Quality Management System through the development / refinement of Clinical QA processes / initiatives as assigned

Partner with GMP Quality and Clinical Operations teams to facilitate the investigation of clinical supply quality issues such as temperature excursions, product complaints and deviations reported from clinical sites.


QUALIFICATIONS: 


  • B.S./B.A. in a science or related life science field or equivalent; advanced scientific degree preferred.
  • 8+ years working within a regulated environment such as Regulatory, Quality, Pharmacovigilance or Clinical Development / Operations within the Biotech or similar industry
  • Proven experience with GCP Quality Management Systems, audit support, and quality oversight of global clinical studies, including knowledge of quality investigation / root cause analysis techniques
  • Minimum of 4 years of experience in a role including responsibility for providing GCP oversight of clinical study activities, preferably at a clinical study sponsor
  • In-depth understanding of GCP requirements for investigational products
  • Extensive practical experience and understanding of clinical quality assurance as applied throughout the clinical development life-cycle
  • Excellent communication skills, both oral and written
  • Excellent interpersonal skills, collaborative approach essential
  • Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities

Base salary compensation range: $152,000 - $199,000Please note that compensation varies depending on location, experience, and a variety of other factors.4DMT provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, gender, sexual orientation, national origin, age, disability, genetic information, marital status, status as a covered veteran, and any other category protected under applicable federal, state, provincial and local laws.Equal Opportunity Employer/Protected Veterans/Individuals with Disabilities

Life at 4D Molecular Therapeutics

The mission of 4D Molecular Therapeutics is to design and develop transformative gene therapy products using our proprietary technology to create novel adeno-associated virus variants to be utilized as treatments for serious unmet medical conditions. Our products are unlocking the full potential of gene therapy to treat, and potentially cure, genetic diseases. A large number of patients and diseases, who previously were not treatable by gene therapy, will be addressable by 4D products. 4D has one of the deepest and most diverse product pipelines in the gene therapy field. Adeno-associated virus (AAV) vectors have emerged as a favored delivery vehicle for gene therapy in the human body. They can deliver the genes for therapeutic proteins to accessible tissues in the body and are generally considered safe. Several AAV gene therapy products are in late-stage clinical development, and one product is approved in the EU (Glybera, Uniqure). However, these first-generation AAV vectors have limited utility for the majority of diseases. Many of these common AAV were discovered as laboratory contaminants and monkey infections, for example; they have not been customized as targeted medicines. In contrast, 4D customized AAV vectors, and the products made from them, are designed to unlock the full potential of gene therapy. Through 4D's Therapeutic Vector Evolution, we are able to create customized vectors solutions to overcome the hurdles identified with first-generation AAV vectors. 4D is creating the ultimate gene therapy products to cure genetic diseases using new customized delivery vehicles (vectors) to shuttle genes into the cells in any organ in the body. This 4D library of vectors will soon include several for the liver, several for the brain, several for the heart, the eye, muscle, and so on. Doctors will be able to hand pick a vector for any patient based on the organ that is diseased.
Thrive Here & What We Value1. Collaborative and innovative work environment2. Emphasis on scientific excellence and innovation3. Focus on patient outcomes and improving lives through genetic medicine4. Opportunities for career growth and professional development5. Commitment to diversity, equity, and inclusion6. Robust technology and IP foundation, including TVE and manufacturing platforms7. Initial product safety and efficacy data substantiates platform value8. Rapid progression from idea to IND9. Expanding opportunities in genetic medicine indications and modalities10. Internal manufacturing capabilities
Your tracker settings

We use cookies and similar methods to recognize visitors and remember their preferences. We also use them to measure ad campaign effectiveness, target ads and analyze site traffic. To learn more about these methods, including how to disable them, view our Cookie Policy or Privacy Policy.

By tapping `Accept`, you consent to the use of these methods by us and third parties. You can always change your tracker preferences by visiting our Cookie Policy.

logo innerThatStartupJob
Discover the best startup and their job positions, all in one place.
Copyright © 2024